TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study - PubMed (original) (raw)

TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study

N Khalil et al. Am J Respir Cell Mol Biol. 1996 Feb.

Abstract

Although it is recognized that three isoforms of transforming growth factor-beta (TGF-beta) exist in mammals, their expression, distribution, and function in injury and repair are not well characterized. Using immunohistochemistry and antibodies to synthetic peptides of TGF-beta 1, TGF-beta 2, and TGF-beta 3, we determined the distribution of TGF-beta isoforms in lung sections with acute and chronic lesions of idiopathic pulmonary fibrosis (IPF), chronic asbestosis and hypersensitivity pneumonitis, as well as non-specific pneumonitis. In lung sections with advanced pulmonary fibrosis and honeycombing, irrespective of the diagnosis, TGF-beta 1 was prominently expressed in epithelial cells and macrophages and was found to be associated with the extracellular matrix. In lungs with early lesions of IPF and only inflammatory changes, TGF-beta 1 was present in alveolar macrophages but TGF-beta 1 was not present in epithelial cells. Small amounts of matrix-associated TGF-beta 1 were present subepithelially in areas of lung sections from patients with IPF with minimal inflammation and no fibrosis. In normal lungs with no evidence of inflammation or fibrosis TGF-beta 1 was not seen in alveolar macrophages, epithelial cells, or extracellularly. TGF-beta 2 and TGF-beta 3 were expressed in alveolar macrophages, epithelial cells, and smooth muscle cells of vessels and bronchi of normal lungs and lungs with both inflammatory and fibrotic changes. Our findings suggest that while TGF-beta 2 and TGF-beta 3 are ubiquitously expressed in the lung, TGF-beta 1 is expressed in epithelial cells of fibrotic lungs where the presence of TGF-beta 1 is not disease-specific but an indication of the chronicity of the injury.

PubMed Disclaimer

Cited by

Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis.
Sakai N, Tager AM. Sakai N, et al. Biochim Biophys Acta. 2013 Jul;1832(7):911-21. doi: 10.1016/j.bbadis.2013.03.001. Epub 2013 Mar 14. Biochim Biophys Acta. 2013. PMID: 23499992 Free PMC article.
Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis.
Lee SY, Lee CM, Ma B, Kamle S, Elias JA, Zhou Y, Lee CG. Lee SY, et al. Front Pharmacol. 2022 Mar 17;13:826471. doi: 10.3389/fphar.2022.826471. eCollection 2022. Front Pharmacol. 2022. PMID: 35370755 Free PMC article. Review.
Transforming growth factor-beta 1 (TGF-beta1) expression in ovine lentivirus-induced lymphoid interstitial pneumonia.
Moreno B, Woodall CJ, Watt NJ, Harkiss GD. Moreno B, et al. Clin Exp Immunol. 1998 Apr;112(1):74-83. doi: 10.1046/j.1365-2249.1998.00553.x. Clin Exp Immunol. 1998. PMID: 9566793 Free PMC article.
Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?
Mustafa DAM, Saida L, Latifi D, Wismans LV, de Koning W, Zeneyedpour L, Luider TM, van den Hoogen B, van Eijck CHJ. Mustafa DAM, et al. Cancers (Basel). 2021 Jun 9;13(12):2896. doi: 10.3390/cancers13122896. Cancers (Basel). 2021. PMID: 34207861 Free PMC article.
Transforming growth factor beta 1 activation, storage, and signaling pathways in idiopathic pulmonary fibrosis in dogs.
Krafft E, Lybaert P, Roels E, Laurila HP, Rajamäki MM, Farnir F, Myllärniemi M, Day MJ, Mc Entee K, Clercx C. Krafft E, et al. J Vet Intern Med. 2014 Nov-Dec;28(6):1666-75. doi: 10.1111/jvim.12432. Epub 2014 Oct 20. J Vet Intern Med. 2014. PMID: 25331544 Free PMC article.

TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study - PubMed (original) (raw)